ENTRY       D02566                      Drug
NAME        Maprotiline (USAN)
FORMULA     C20H23N
EXACT_MASS  277.1831
MOL_WEIGHT  277.4033
CLASS       Neuropsychiatric agent
             DG01730  Non-selective monoamine reuptake inhibitor
             DG01729  Tetracyclic antidepressant
            Metabolizing enzyme substrate
             DG01644  CYP2D6 substrate
REMARK      Same as: C07107
            ATC code: N06AA21
            Chemical structure group: DG00941
            Product (DG00941): D00818<JP>
EFFICACY    Antidepressant, Selective noradrenaline reuptake inhibitor (NRI)
TARGET      SLC6A2 (NAT1) [HSA:6530] [KO:K05035]
  PATHWAY   hsa04721(6530)  Synaptic vesicle cycle
METABOLISM  Enzyme: CYP2D6 [HSA:1565]
INTERACTION  
STR_MAP     map07027  Antidepressants
            map07234  Neurotransmitter transporter inhibitors
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N06 PSYCHOANALEPTICS
               N06A ANTIDEPRESSANTS
                N06AA Non-selective monoamine reuptake inhibitors
                 N06AA21 Maprotiline
                  D02566  Maprotiline (USAN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01730  Non-selective monoamine reuptake inhibitor
               DG00941  Maprotiline
                D02566  Maprotiline
              DG01729  Tetracyclic antidepressant
               DG00941  Maprotiline
                D02566  Maprotiline
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00941  Maprotiline
                D02566  Maprotiline
            Target-based classification of drugs [BR:br08310]
             Transporters
              Solute carrier family
               SLC6
                SLC6A2 (NAT1)
                 D02566  Maprotiline (USAN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D02566
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01730  Non-selective monoamine reuptake inhibitor
               DG00941  Maprotiline
              DG01729  Tetracyclic antidepressant
               DG00941  Maprotiline
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00941  Maprotiline
DBLINKS     CAS: 10262-69-8
            PubChem: 17396737
            ChEBI: 6690
            LigandBox: D02566
            NIKKAJI: J9.818C
ATOM        21
            1   C1x C    21.9568  -16.7489
            2   C1x C    21.9568  -17.8749
            3   C1z C    21.4642  -15.8341
            4   C8y C    20.1975  -16.5378
            5   C8y C    22.7309  -16.5378
            6   C1b C    21.4642  -14.3563
            7   C8y C    20.1975  -17.9452
            8   C8x C    19.0012  -15.7637
            9   C8y C    22.7309  -18.0156
            10  C8x C    23.9976  -15.8341
            11  C1b C    22.7309  -13.6525
            12  C1y C    21.4642  -18.7193
            13  C8x C    18.9308  -18.6490
            14  C8x C    17.7345  -16.4674
            15  C8x C    23.9272  -18.7193
            16  C8x C    25.2643  -16.6082
            17  C1b C    23.9272  -14.4266
            18  C8x C    17.7345  -17.9452
            19  C8x C    25.2643  -18.0156
            20  N1b N    25.2643  -13.7229
            21  C1a C    26.5310  -14.4266
BOND        24
            1     1   2 1
            2     3   4 1
            3     3   5 1
            4     3   6 1
            5     4   7 1
            6     4   8 2
            7     5   9 2
            8     5  10 1
            9     6  11 1
            10    7  12 1
            11    7  13 2
            12    8  14 1
            13    9  15 1
            14   10  16 2
            15   11  17 1
            16   13  18 1
            17   15  19 2
            18   17  20 1
            19   20  21 1
            20    9  12 1
            21   14  18 2
            22   16  19 1
            23    2  12 1
            24    1   3 1
///
